Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.000
+0.033 (3.38%)
Jun 16, 2026, 9:40 AM EST
Nuo Therapeutics Market Cap
Nuo Therapeutics has a market cap or net worth of $46.83 million as of June 16, 2026. Its market cap has decreased by -33.32% in one year.
Market Cap
46.83M
Enterprise Value
46.64M
Revenue
4.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.00
Market Cap Chart
Since February 14, 2017, Nuo Therapeutics's market cap has increased from 19.85M to 46.83M, an increase of 135.86%. That is a compound annual growth rate of 9.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 46.83M | -50.66% |
| Dec 31, 2025 | 94.91M | 44.81% |
| Dec 31, 2024 | 65.54M | 169.36% |
| Dec 29, 2023 | 24.33M | -61.19% |
| Dec 23, 2022 | 62.70M | 360.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NDT Pharmaceuticals | 100.29M |
| HST Global | 99.00M |
| BioStem Technologies | 72.59M |
| Sangamo Therapeutics | 68.36M |
| Cell Source | 55.72M |
| ProText Mobility | 52.31M |
| Vicapsys Life Sciences | 47.26M |
| Provectus Biopharmaceuticals | 26.21M |